The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
Background: Treat to target (TTT) is a broad concept for treating patients with rheumatoid arthritis (RA). It involves setting a treatment target, usually remission or low disease activity (LDA). This is often combined with frequent patient assessment and intensive and rapidly adjusted drug treatmen...
Main Authors: | Allan Wailoo, Emma S Hock, Matt Stevenson, Marrissa Martyn-St James, Andrew Rawdin, Emma Simpson, Ruth Wong, Naila Dracup, David L Scott, Adam Young |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2017-11-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta21710 |
Similar Items
-
What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis
by: Emma Simpson, et al.
Published: (2018-04-01) -
Indirect costs of the Rheumatoid arthritis in Poland
by: Emilia Howoruszko, et al.
Published: (2019-05-01) -
Indirect costs of the Rheumatoid arthritis in Poland
by: Emilia Howoruszko, et al.
Published: (2019-05-01) -
Systematic review on the comparative effectiveness of foot orthoses in patients with rheumatoid arthritis
by: Marloes Tenten-Diepenmaat, et al.
Published: (2019-06-01) -
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation
by: Matt Stevenson, et al.
Published: (2016-04-01)